NOT:ETR
Novartis
124,92 €
arrow_upward
+0,13%(+0,16) 1 d.
5. 10., 17:35:31 GMT+2 · EUR
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre NOT…
Otvoriť
126,12 €
Vysoká
127,00 €
Nízka
124,48 €
Trh. kap.
285,56 mld.
Priem. obj.
6,54 tis.
Objem
4,13 tis.
Max. za 52 týž.
144,12 €
Min. za 52 týž.
104,52 €
Počet zamestnancov
75 tis.
Otvoriť
126,12 €
Vysoká
127,00 €
Nízka
124,48 €
Trh. kap.
285,56 mld.
Priem. obj.
6,54 tis.
Objem
4,13 tis.
Max. za 52 týž.
144,12 €
Min. za 52 týž.
104,52 €
Počet zamestnancov
75 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
NJBIZ
·
pred 2 hodinami
Novartis signs $7.8B mRNA deal with Chinese biotech
AD HOC NEWS
·
pred 3 hodinami
Novartis stock after-hours at EUR 124.59: minus 0.61 percent versus prior close
AD HOC NEWS
·
pred 4 hodinami
Novartis stock gets a USD 575 million mRNA deal
Yahoo Finance
·
pred 5 hodinami
Novartis Strengthens RNA Therapeutics Pipeline With $7.8B Abogen Deal
Profil
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
Informácie o subjekte Novartis
Generálny riaditeľVasant Narasimhan
Zamestnanci75,3 tis.
Dátum založenia7. 3. 1996
Hlavné sídloBazilej, Bazilej-mesto, Švajčiarsko
Odvetvie-
Webnovartis.com